Seeking Alpha
  • Michael Bryant
    Complete Genomics (GNOM) and its DNA sequencing technology looks good. But Neostem (NBS) and stem cells...no. http://yhoo.it/KSyRFj
    5/24/12
    Reply (6)
    • The Berenstain Bulls: Disagree. Long NBS, PSTI, NVLX. The stem cell industry is the most undervalued sector in the market place right now period.
      5/24/12
    • The Berenstain Bulls: Life isn't very important if you're not living...
      5/24/12
    • Michael Bryant: It's a political industry. Never play something based on politics.
      5/24/12
    • Noreika: Isn't NBS like investing in the picks & shovels of the industry? Long NBS, adding into ACTC small position.
      5/25/12
    • Maria Auziliadora: GNOM looks good and the other biotechs do too
      5/25/12
    • The Berenstain Bulls: @Maria: Yeah, I like GNOM as well, currently long a few shares.
      1/2/13